Showing 34,779 results

Filters
New & experimental hepatitis C treatment

Janssen Creates new Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Editor's pick
Janssen press release
20 April 2012
Undetectable viral load & treatment as prevention

Guidance on couples HIV testing and counselling, including antiretroviral therapy for treatment and prevention in serodiscordant couples

Editor's pick
World Health Organization
20 April 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
New & experimental HIV treatments

Cobicistat Doubles to Triples Exposure of GS-7340 (a Tenofovir Prodrug) and Resulting Tenofovir

Editor's pick
NATAP
20 April 2012
New & experimental hepatitis C treatment

Investigational Compound Peginterferon Lambda Achieved SVR24 Rates Comparable to Peginterferon Alfa with Fewer Flu-Like and Musculoskeletal Symptoms in Phase IIb Study in Treatment-Naive Genotype 2 or 3 Hepatitis C Patients

Editor's pick
BMS press release
20 April 2012
New & experimental hepatitis C treatment

Gilead’s Experimental Hepatitis C Drug Cured 88% Post-Therapy

Editor's pick
Bloomberg
20 April 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial

Editor's pick
Bloomberg
20 April 2012
New & experimental hepatitis C treatment

Medivir Hep C Drug Cures 80% of Patients Post-Treatment

Editor's pick
Bloomberg BusinessWeek
20 April 2012
New & experimental hepatitis C treatment

Gilead, Bristol hepatitis C trial data impresses

Editor's pick
Reuters
20 April 2012
New & experimental hepatitis C treatment

Gilead, Bristol-Myers Squibb Put Profits Ahead of Best Care for Hep C Patients

Editor's pick
The Street
20 April 2012
Global health initiatives

Can the Global Fund's new management change its fortunes?

Editor's pick
The Guardian
20 April 2012
Money

UK: NAT launches new report on HIV social care spending and services

Editor's pick
NAT press release
20 April 2012
Mental & emotional health problems

Depression associated with socioeconomic difficulties and poor virological outcomes in UK HIV patients

News
20 April 2012
Adherence

Financial incentives and motivational interviewing being used to improve adherence in young people

News
20 April 2012
Government, leadership & policy

Three Big HIV Days in May at the FDA

Editor's pick
AIDSMeds
19 April 2012
Global health initiatives

US Reveals Nearly $1.5 Billion in Unspent AIDS Money

Editor's pick
Global Post
19 April 2012
HIV prevention policy

US National Institutes of Health under fire for grants toward creation of homoerotic website

Editor's pick
Fox News
19 April 2012
New & experimental hepatitis C treatment

EASL-Anemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy

Editor's pick
HCV New Drugs Research
19 April 2012
New & experimental hepatitis C treatment

EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin

Editor's pick
HCV New Drugs Research
19 April 2012
Vaginal rings & topical PrEP

Will women use microbicides to protect themselves against HIV?

Editor's pick
Eurekalert Medicine & Health
19 April 2012
Hepatitis & HIV

Chronic hepatic diseases generate high costs to Europe

Editor's pick
Eurekalert Medicine & Health
19 April 2012
New & experimental hepatitis C treatment

Recapitulation of the entire hepatitis C virus life in engineered mouse cell lines

Editor's pick
Eurekalert Medicine & Health
19 April 2012
Testing & health monitoring

Testing, Counseling Of Cocaine And Heroin Users Reduces Unprotected Sex

Editor's pick
HIV / AIDS News From Medical News Today
19 April 2012
Harm reduction

Naloxone Debate: FDA Hears Testimony About Making an Opioid Overdose Antidote Nonprescription

Editor's pick
Time
19 April 2012